Established Tesamorelin stacks
Visceral Fat & Metabolic Research
Goal: Complementary visceral fat and appetite regulation signals
Investigators have modeled combining GHRH-axis stimulation with GLP-1 agonism for synergistic metabolic effects. This is a research framing only.
GH Axis Dual Stimulation
Goal: GHRH + GHRP combinatorial GH release
Pairing Tesamorelin with a GHRP like Ipamorelin is studied to amplify pituitary GH output beyond what either compound achieves alone.
How to think about stacking
- Mechanism diversity beats redundancy. Pairing compounds that hit different pathways usually outperforms stacking two compounds with similar mechanisms.
- Track one variable at a time. Starting two peptides simultaneously makes it impossible to attribute effects. Research protocols typically introduce stacks sequentially.
- Side-effect interactions. Some peptides compound each other's side effects (e.g., GLP-1 agonists with other GI-active compounds). Review side-effect profiles before stacking.